Drug Discovery

Can An Experimental Drug GL-II-73 Reverse Alzheimer's Memory Loss?
Research & Development Can An Experimental Drug GL-II-73 Reverse Alzheimer's Memory Loss?

Imagine a world where the devastating effects of Alzheimer's disease can be reversed through an innovative new drug. This scenario may soon become a reality, thanks to groundbreaking research from the Centre for Addiction and Mental Health (CAMH). The study investigates the impact of GL-II-73,

Can Exenatide Offer Hope for Parkinson's Disease Treatment?
Research & Development Can Exenatide Offer Hope for Parkinson's Disease Treatment?

The search for effective treatments for Parkinson's disease has been long and arduous, with researchers globally dedicating countless hours to uncover potential therapies. One promising candidate, exenatide, a GLP-1 drug traditionally used to treat Type 2 diabetes, recently underwent scrutiny

AI and Automation Revolutionize Biopharma R&D in Large Companies
Tech & Innovation AI and Automation Revolutionize Biopharma R&D in Large Companies

The 2024 Biopharma Technology Landscape report by Benchling, a leading R&D cloud software company, reveals the transformative impact of artificial intelligence (AI) and automation on biopharma research and development (R&D). The report highlights how large biopharma companies are leveraging

UK Biotech Sector Sees Record Investments and Growth Amid Challenges
Management & Regulatory UK Biotech Sector Sees Record Investments and Growth Amid Challenges

The biotech and healthcare sectors in the United Kingdom experienced a remarkable year in 2024, marked by substantial financial investments, significant trends, and notable challenges. Grounded in a report by the UK BioIndustry Association (BIA), this analysis delves into the pivotal investment

How Will Biopharma Cope with Federal Funding Uncertainty?
Research & Development How Will Biopharma Cope with Federal Funding Uncertainty?

The recent moves by the Trump administration have cast a shadow of uncertainty over the biopharma sector, causing significant turmoil among companies relying on federal grants for clinical trials and drug development. The Office of Management and Budget (OMB) issued a memo on Monday that threatened

Breakthrough Antibody Therapy Offers Durable Protection Against H5N1
Research & Development Breakthrough Antibody Therapy Offers Durable Protection Against H5N1

In a significant development in avian flu research, scientists from the University of Pittsburgh and the NIH Vaccine Research Center have crafted an innovative antibody therapy aimed at tackling the severe H5N1 avian flu virus in monkeys. This new therapy focuses on a broadly neutralizing antibody,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later